Lipid Based Food Additives for Treating Patients With Dry Mouth
NCT00422370 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2007-01-17
Summary
Over 10% of adult population suffers from dry mouth (xerostomia). The aim of this double blind prospective clinical trial is to examine a new lipid based food additive formulation to ease mouth dryness in these patients.
Conditions
- Xerostomia
Interventions
- DEVICE
-
lipid based additives based on vegetable oil & lecithin
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Doron J Aframian, DMD PhD · Reference: Kelly HM et al. Bioadhesive,rheological, lubricant and other aspectes of an oral gel formulation intended for the treatment of xerostomia. Int J Phramac. 2004; 278: 391-406
-
Doron J Aframian, DMD PhD · Salivary Gland Clinic, Department of Oral Medicine The Hebrew University-Hadassah School of Dental Medicine Jerusalem, Israel P.O.B 12272, Zip code 91120
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
More Related Trials
-
Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study
NCT04206826 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effects of Natural Products on Management of Xerostomia
NCT06217614 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray
NCT04186806 ·Status: COMPLETED ·Phase: NA
-
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
NCT03530735 ·Status: UNKNOWN ·Phase: NA
-
Xylitol Disk Use in Adults With Dry Mouth
NCT01823445 ·Status: COMPLETED ·Phase: NA
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
Green Tea Lozenges for the Management of Dry Mouth
NCT01647737 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Local Pilocarpine for Relieving Dry Mouth
NCT04195100 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00003686 ·Status: TERMINATED ·Phase: PHASE3
-
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
NCT06703372 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
NCT00332618 ·Status: COMPLETED
-
Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication
NCT01960101 ·Status: WITHDRAWN ·Phase: NA
-
Effect of 0.1% Pilocarpine Mouthwash on Xerostomia
NCT01627626 ·Status: COMPLETED ·Phase: NA
-
the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia
NCT04252209 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
Topical Management of Xerostomia With Dry Mouth Products
NCT03611283 ·Status: COMPLETED ·Phase: NA
-
Duration of Effect of Biotene Spray in Patients With Dry Mouth
NCT03663231 ·Status: COMPLETED ·Phase: NA
-
Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water Control
NCT04189081 ·Status: COMPLETED ·Phase: NA
-
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
NCT03005041 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children
NCT01044030 ·Status: COMPLETED ·Phase: PHASE3
-
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
NCT06805448 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
"Hyaluronan" Formulation for Dry Mouth in Sleep Apnea Patients
NCT03295019 ·Status: UNKNOWN ·Phase: NA